A reproducible immunopotency assay to measure mesenchymal stromal cell-mediated T-cell suppression.
A reproducible immunopotency assay to measure mesenchymal stromal cell-mediated T-cell suppression.
复制标题
DOI:
10.1016/j.jcyt.2014.10.002
复制
发表时间:
2015-02
期刊:
影响因子:
4.5
通讯作者:
Hematti, Peiman
中科院分区:
文献类型:
--
作者:
Bloom, Debra D.;Centanni, John M.;Bhatia, Neehar;Emler, Carol A.;Drier, Diana;Leverson, Glen E.;Mckenna, David H., Jr.;Gee, Adrian P.;Lindblad, Robert;Hei, Derek J.;Hematti, Peiman
The T cell suppressive property of bone marrow derived mesenchymal stromal cells (MSCs) has been considered a major mode of action and basis for their utilization in a number of human clinical trials. However, there is no well-established reproducible assay to measure MSC-mediated T cell suppression. At the University of Wisconsin-Madison Production Assistance for Cellular Therapy (PACT) Center we developed an in vitro quality control T cell suppression immunopotency assay (IPA) which utilizes anti-CD3 and anti-CD28 antibodies to stimulate T cell proliferation. We measured MSC-induced suppression of CD4+ T cell proliferation at various effector to target cell ratios using defined peripheral blood mononuclear cells and in parallel compared to a reference standard MSC product. We calculated an IPA value for suppression of CD4+ T cells for each MSC product. Eleven MSC products generated at three independent PACT centers were evaluated for cell surface phenotypic markers and T cell suppressive properties. Flow cytometry results demonstrated typical MSC cell surface marker profiles. There was significant variability in the level of suppression of T cell proliferation with IPA values ranging from 27% to 88%. However, MSC suppression did not correlate with HLA-DR expression. We have developed a reproducible immunopotency assay to measure allogeneic MSC-mediated suppression of CD4+ T cells. Additional studies may be warranted to determine how these in vitro assay results may correlate with other immunomodulatory properties of MSCs, in addition to evaluating the ability of this assay to predict in vivo efficacy.
登录
查看更多内容
影响因子:
2.6
作者:
Kim, Jaehyup;Hematti, Peiman
通讯作者:
Hematti, Peiman
影响因子:
4.5
作者:
Horwitz, E. M.;Dominici, M.
通讯作者:
Dominici, M.
影响因子:
20.3
作者:
Aggarwal, S;Pittenger, MF
通讯作者:
Pittenger, MF
影响因子:
4.4
作者:
Ghannam, Soufiane;Pene, Jerome;Yssel, Hans
通讯作者:
Yssel, Hans
影响因子:
2.8
作者:
CAPLAN, AI
通讯作者:
CAPLAN, AI